Pear Bio Companies
Pear Bio is a computational biology company that specializes in using computer vision to analyze patient 3D immune-microtumors. Their main goal is to predict treatment response and discover first-in-class therapies. They have developed a unique 3D immune-microtumor technology that recreates core parts of the human tumor-immune microenvironment for functional precision medicine testing and drug discovery. Their platform combines 3D cell culture, functional testing, computer vision, and multi-omics analysis. Pear Bio is actively involved in clinical trials to predict patient response to therapy and also has an internal drug discovery pipeline based on the analysis of patient tumor and blood samples and real-world patient data.
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
London, England, United Kingdom
Founded Date:
2017
Employees Number:
40
Register and Claim Ownership